Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Biora Therapeutics Inc BIOR

Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and systemic, needle-free delivery of biotherapeutics. The Company’s pipeline includes two therapeutic delivery platforms: NaviCap and BioJet. The NaviCap, targeted oral delivery platform, which is designed to improve outcomes for... see more

NDAQ:BIOR - Post Discussion

Biora Therapeutics Inc > 4 RISKY STOCKS TO AVOID ON DECLINING REVENUES AND DOWNGRADES
View:
Post by AviseAnalytics on Dec 07, 2021 6:48am

4 RISKY STOCKS TO AVOID ON DECLINING REVENUES AND DOWNGRADES

$PROG $SUNW $UPLD $PRPL
 
This week we bring to you four companies, namely Sunworks (NASDAQ: SUNW)Progenity Inc (NASDAQ: PROG)Upland Software Inc (NASDAQ: UPLD) and Purple Innovation Inc (NASDAQ: PRPL) that could turn out be to vulnerable investments, in view of the challenges being faced by these companies, such as loss of market share, dwindling revenues, tough competition or short seller interest.
 
Read on to learn more:

https://www.aviseanalytics.com/4-risky-stocks-to-avoid-on-declining-revenues-and-downgrades/
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities